Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
ArriVent BioPharma, Inc. (AVBP) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-35.54M |
|
-- |
|
-- |
|
$38.82M |
|
$-38.82M |
|
$3.28M |
|
$-35.54M |
|
$-35.54M |
|
$-35.54M |
|
$-35.54M |
|
$-35.54M |
|
$-35.54M |
|
$-38.82M |
|
$-38.82M |
|
38.46M |
|
38.46M |
|
$-0.69 |
|
$-0.69 |
|
| Balance Sheet Financials | |
$332.90M |
|
-- |
|
$0.27M |
|
$333.17M |
|
$25.95M |
|
-- |
|
-- |
|
$25.95M |
|
$307.22M |
|
$307.22M |
|
$307.22M |
|
42.45M |
|
| Cash Flow Statement Financials | |
$-160.59M |
|
$-71.23M |
|
$203.06M |
|
$74.29M |
|
$45.54M |
|
$-28.75M |
|
$12.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.83 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-160.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.57% |
|
-11.57% |
|
-10.67% |
|
-11.57% |
|
$7.24 |
|
$-4.18 |
|
$-4.18 |
|